Skip to main content
. 2016 Mar 25;95(12):e3170. doi: 10.1097/MD.0000000000003170

FIGURE 4.

FIGURE 4

Comparison of incidence of AARs between Ultravist-370 and Isovue-370. A, Overall incidence (P < 0.001); B, Incidence of mild AARs (P < 0.001); C, Incidence of moderate AARs (P = 0.152); D, Incidence of severe AARs (P = 0.584). AARs = acute adverse reactions.